Anadys begins dosing in ANA598 Stage IIb research for hepatitis C Anadys Pharmaceuticals.

Anadys begins dosing in ANA598 Stage IIb research for hepatitis C Anadys Pharmaceuticals, Inc. Announced today that dosing offers begun in the Phase IIb research of ANA598 in combination with pegylated interferon and ribavirin in hepatitis C patients http://silagra-rx.com . THE BUSINESS expects to receive Week 8 antiviral response data for treatment-naive patients by the finish of the second one fourth of 2011, Week 12 antiviral response data for treatment-experienced patients in the third one fourth of 2011 and Week 24 antiviral response data for both groupings in the fourth quarter of 2011. ..

cipla silagra online

Pre-clinical studies claim that they may also be effective in treating atopic dermatitis. This trial is intended to comprehend the potential of every compound to treat the condition, and, if effective, determine which compound to advance further in development. .. Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis Anacor Pharmaceuticals announced today that the 1st patient offers been dosed in a Stage 2 trial of AN2728 and AN2898 to determine safety, efficacy and tolerability of the two compounds for the topical treatment of mild-to-average atopic dermatitis.

Random entries

Other entries from category "pharmacy":